GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for ArQule Stock and on which exchange is it traded?
The symbol for ArQule is ARQL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ArQule Stock?
ArQule holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ArQule Stock?
ArQule Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ArQule Stock.

What's the current price of ArQule Stock?
As of the end of day on the 2020-04-15, the price of an ArQule (ARQL) share was $20.00.

What is the 52-week high and low for ArQule Stock?
The 52-week high for ArQule Stock is $20.45 and the 52-week low is $5.76.
Click to get the best stock tips daily for free!

About ArQule

ArQule ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer and non-small cell lung cancer; Phase II clinical trial for the treatment of mesotheli... ARQL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT